Wolverine Trading, LLC Cerevel Therapeutics Holdings, Inc. Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$38.96 - $42.75 $35,064 - $38,475	-900 Reduced 12.0%	6,600 $269,000
Q1 2024 May 15, 2024	SELL	$40.88 - $43.27 $200,312 - $212,023	-4,900 Reduced 39.52%	7,500 $317,000
Q4 2023 Feb 14, 2024	BUY	$20.27 - $42.44 $251,348 - $526,256	12,400 New	12,400 $525,000
Q1 2023 May 15, 2023	BUY	$22.82 - $35.32 $349,146 - $540,396	15,300 Added 131.9%	26,900 $645,000
Q4 2022 Feb 14, 2023	BUY	$25.35 - $31.96 $294,060 - $370,736	11,600 New	11,600 $366,000

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.